ATI Physical Therapy, Inc.
NYSE:ATIP
2.43 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 189.987 | 188.112 | 181.472 | 182.292 | 177.455 | 172.337 | 166.932 | 161.764 | 156.792 | 163.293 | 153.822 | 155.763 | 159.013 | 164.033 | 149.062 | 153.106 | 148.655 | 107.754 | 176.718 |
| Cost of Revenue
| 164.972 | 158.064 | 157.322 | 154.704 | 149.788 | 145.764 | 143.581 | 139.783 | 141.726 | 140.011 | 139.03 | 135.879 | 132.603 | 124.996 | 123.95 | 121.941 | 117.222 | 92.674 | 95.349 |
| Gross Profit
| 25.015 | 30.048 | 24.15 | 27.588 | 27.667 | 26.573 | 23.351 | 21.981 | 15.066 | 23.282 | 14.792 | 19.884 | 26.41 | 39.037 | 25.112 | 31.165 | 31.433 | 15.08 | 81.369 |
| Gross Profit Ratio
| 0.132 | 0.16 | 0.133 | 0.151 | 0.156 | 0.154 | 0.14 | 0.136 | 0.096 | 0.143 | 0.096 | 0.128 | 0.166 | 0.238 | 0.168 | 0.204 | 0.211 | 0.14 | 0.46 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 20.521 | 0 | 0 | 0 | 22.929 | 0 | 0 | 0 | 24.797 | 0 | 0 | 0 | 25.232 | 1.174 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 4.5 | 0 | 0 | 0 | 4.7 | 0 | 0 | 0 | 5.1 | 0 | 0 | 0 | 4.8 | 24.852 | 0 | 0 |
| SG&A
| 23.772 | 23.162 | 28.45 | 25.021 | 25.085 | 36.573 | 30.595 | 27.629 | 25.263 | 31.808 | 30.024 | 29.897 | 30.795 | 26.391 | 24.726 | 30.032 | 26.026 | 24.791 | 68.9 |
| Other Expenses
| 0 | 5.557 | 5.501 | 23.783 | -0.117 | -0.618 | 4.125 | 2.461 | 2.797 | 3.506 | 5.105 | 5.59 | -0.052 | -19.663 | -0.153 | 23.914 | 23.117 | 44.103 | 0 |
| Operating Expenses
| 23.772 | 23.162 | 28.45 | 25.021 | 28.431 | 38.933 | 34.72 | 30.09 | 28.06 | 35.314 | 35.129 | 31.996 | 34.309 | 29.976 | 31.897 | 33.364 | 28.964 | 28.732 | 69.032 |
| Operating Income
| 1.129 | 6.886 | -4.3 | 2.567 | 0.764 | -12.36 | -11.723 | -8.261 | -13.189 | -12.032 | -20.337 | -12.112 | 509.261 | 9.061 | -6.785 | -2.199 | 2.469 | -13.652 | 12.469 |
| Operating Income Ratio
| 0.006 | 0.037 | -0.024 | 0.014 | 0.004 | -0.072 | -0.07 | -0.051 | -0.084 | -0.074 | -0.132 | -0.078 | 3.203 | 0.055 | -0.046 | -0.014 | 0.017 | -0.127 | 0.071 |
| Total Other Income Expenses Net
| -34.126 | -9.191 | -9.357 | -4.789 | -13.716 | -9.3 | -13.779 | -99.144 | -4.255 | -8.904 | 14.574 | 8.421 | 154.764 | -28.374 | -21.548 | 2.356 | 0.875 | 21.816 | -22.367 |
| Income Before Tax
| -32.997 | -2.565 | -13.657 | -2.222 | -14.48 | -21.66 | -25.148 | -107.405 | -123.912 | -148.756 | -161.504 | -3.691 | -354.497 | -5.526 | -28.333 | 0.157 | 3.344 | 8.164 | -9.898 |
| Income Before Tax Ratio
| -0.174 | -0.014 | -0.075 | -0.012 | -0.082 | -0.126 | -0.151 | -0.664 | -0.79 | -0.911 | -1.05 | -0.024 | -2.229 | -0.034 | -0.19 | 0.001 | 0.022 | 0.076 | -0.056 |
| Income Tax Expense
| -0.128 | -0.013 | -0.134 | 2.286 | 0.131 | 0.089 | 0.062 | -4.998 | -7.218 | -13.033 | -23.281 | -12.427 | -28.842 | -20.183 | -10.515 | -2.033 | 2.322 | 3.568 | 1.792 |
| Net Income
| -33.814 | -3.735 | -14.651 | -5.623 | -15.197 | -22.705 | -25.21 | -102.407 | -116.694 | -135.723 | -138.223 | 8.736 | -325.655 | -5.526 | -19.127 | 1.203 | 0.109 | 2.741 | -9.436 |
| Net Income Ratio
| -0.178 | -0.02 | -0.081 | -0.031 | -0.086 | -0.132 | -0.151 | -0.633 | -0.744 | -0.831 | -0.899 | 0.056 | -2.048 | -0.034 | -0.128 | 0.008 | 0.001 | 0.025 | -0.053 |
| EPS
| -9.38 | -0.86 | -3.51 | -1.35 | -3.66 | -5.51 | -6.15 | -25.81 | -28.56 | -33.29 | -34.64 | 2.21 | -82.75 | -1.98 | -7.5 | 0.47 | 0.043 | 0.96 | -3.678 |
| EPS Diluted
| -9.38 | -0.86 | -3.51 | -1.35 | -3.66 | -5.51 | -6.15 | -25.81 | -28.56 | -33.29 | -34.56 | 2.21 | -82.66 | -1.98 | -7.45 | 0.41 | 0.043 | 0.96 | -3.678 |
| EBITDA
| -9.572 | 32.5 | 21.709 | 33.874 | 22.306 | 4.372 | -1.521 | -71.731 | -89.94 | -114.855 | -130.93 | 25.197 | -333.98 | -443.181 | 13.736 | 42.929 | 46.405 | -0.016 | 22.454 |
| EBITDA Ratio
| -0.05 | 0.144 | 0.091 | 0.13 | 0.047 | 0.048 | 0.059 | 0.086 | 0.057 | -0.075 | -0.008 | 0.097 | -0.05 | -0.065 | 0.092 | 0.28 | 0.312 | 0.283 | 0.127 |